Precision medicine is an emerging field that takes into account individual heterogeneity to inform better clinical practice. In clinical trials, the evaluation of treatment effect heterogeneity is an important component, and recently, many statistical methods have been proposed for stratifying patients into different subgroups based on such heterogeneity. However, the majority of existing methods developed for this purpose focus on the case with a dichotomous treatment and are not directly applicable to multi-arm trials. In this paper, we consider the problem of patient stratification in multi-arm trial settings and propose a two-stage procedure within the Bayesian nonparametric framework. Specifically, we first use Bayesian additive regression trees (BART) to predict potential outcomes (treatment responses) under different treatment options for each patient, and then we leverage Bayesian profile regression to cluster patients into subgroups according to their baseline characteristics and predicted potential outcomes. We further embed a variable selection procedure into our proposed framework to identify the patient characteristics that actively "drive" the clustering structure. We conduct simulation studies to examine the performance of our proposed method and demonstrate the method by applying it to a UK-based multi-arm blood donation trial, wherein our method uncovers five clinically meaningful donor subgroups.
翻译:精密医学是一个新兴领域,它考虑到个别异质性,为更好的临床实践提供信息。在临床试验中,对治疗效果异质性的评价是一个重要组成部分,最近,提出了许多统计方法,根据这种异质性将病人分为不同的分组;然而,为此目的而开发的大多数现有方法都侧重于有二分治疗的案例,并且不直接适用于多臂试验。在本文件中,我们考虑了多臂试验环境中病人分层的问题,并在巴伊西亚非对称框架内提出一个两阶段程序。具体地说,我们首先使用贝伊西亚累加回归树(BART)来预测每个病人在不同的治疗选项下的潜在结果(治疗反应),然后我们根据病人的基线特征和预测潜在结果,利用贝伊斯剖面回归法将病人分组纳入分组。我们进一步将可变选择程序嵌入我们提议的框架,以确定积极“驱动”聚合结构的病人特征。我们进行模拟研究,以审查我们拟议方法的性能,并通过将这一方法应用于一个有意义的临床分组,检验我们的临床试验。